These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29308544)

  • 1. The LRRK2 signalling system.
    Price A; Manzoni C; Cookson MR; Lewis PA
    Cell Tissue Res; 2018 Jul; 373(1):39-50. PubMed ID: 29308544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease.
    Herbst S; Lewis PA
    Biochem J; 2021 Jul; 478(14):2945-2951. PubMed ID: 34328508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unconventional G-protein cycle of LRRK2 and Roco proteins.
    Terheyden S; Nederveen-Schippers LM; Kortholt A
    Biochem Soc Trans; 2016 Dec; 44(6):1611-1616. PubMed ID: 27913669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 links genetic and sporadic Parkinson's disease.
    Kluss JH; Mamais A; Cookson MR
    Biochem Soc Trans; 2019 Apr; 47(2):651-661. PubMed ID: 30837320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LRRK2-macroautophagy axis and its relevance to Parkinson's disease.
    Manzoni C
    Biochem Soc Trans; 2017 Feb; 45(1):155-162. PubMed ID: 28202669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson's-associated protein.
    Guaitoli G; Gilsbach BK; Raimondi F; Gloeckner CJ
    Biochem Soc Trans; 2016 Dec; 44(6):1635-1641. PubMed ID: 27913672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.
    Berwick DC; Javaheri B; Wetzel A; Hopkinson M; Nixon-Abell J; Grannò S; Pitsillides AA; Harvey K
    Mol Neurodegener; 2017 Jan; 12(1):9. PubMed ID: 28103901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological Functions of LRRK2 in Parkinson's Disease.
    Jeong GR; Lee BD
    Cells; 2020 Nov; 9(12):. PubMed ID: 33266247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 signaling in neurodegeneration: two decades of progress.
    Iannotta L; Greggio E
    Essays Biochem; 2021 Dec; 65(7):859-872. PubMed ID: 34897411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
    Cookson MR
    Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for chemical modulators for LRRK2.
    Mortiboys H
    Biochem Soc Trans; 2016 Dec; 44(6):1617-1623. PubMed ID: 27913670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homologue of the Parkinson's disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover.
    Deyaert E; Wauters L; Guaitoli G; Konijnenberg A; Leemans M; Terheyden S; Petrovic A; Gallardo R; Nederveen-Schippers LM; Athanasopoulos PS; Pots H; Van Haastert PJM; Sobott F; Gloeckner CJ; Efremov R; Kortholt A; Versées W
    Nat Commun; 2017 Oct; 8(1):1008. PubMed ID: 29044096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 Phosphorylation: Behind the Scenes.
    De Wit T; Baekelandt V; Lobbestael E
    Neuroscientist; 2018 Oct; 24(5):486-500. PubMed ID: 29385885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.
    Greggio E
    Biochem Soc Trans; 2012 Oct; 40(5):1058-62. PubMed ID: 22988865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
    Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting.
    Xiong Y; Yu J
    Trends Mol Med; 2024 Oct; 30(10):982-996. PubMed ID: 39153957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of phospho-specific Rab protein antibodies to monitor
    Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR
    Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years.
    Filippini A; Gennarelli M; Russo I
    Biochem Soc Trans; 2021 Jun; 49(3):1375-1384. PubMed ID: 33960369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal death signaling pathways triggered by mutant LRRK2.
    Rideout HJ
    Biochem Soc Trans; 2017 Feb; 45(1):123-129. PubMed ID: 28202665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.